Rare diseases investors
5 investors that name Rare diseases among their sectors are recorded here: 3 venture capital firms, 1 accelerator and 1 corporate venture arm. Stated investment stages run from pre-seed to growth. Most are headquartered in Canada (1), Switzerland (1) and Italy (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Agent Capital, LLC Rare Diseases · Oncology · Neurology · Immunology |
Direct investor | Venture capital | Seed – Growth | Waltham, United States |
| Amplitude Venture Capital precision medicine · biotechnology · drug discovery · oncology |
Direct investor | Venture capital | Not stated | Montreal, Canada |
| BaseLaunch biotech · therapeutics · oncology · immunology |
Direct investor | Accelerator | Pre-seed – Series A | Basel, Switzerland |
| Claris Ventures biopharma · oncology · immunology · rare diseases |
Direct investor | Venture capital | Pre-seed – Series A | Turin, Italy |
| Sanofi Ventures Rare diseases · Immunology and inflammation · Oncology · Cell and gene therapy |
Direct investor | Corporate venture | Seed – Series C+ |